Curis Inc. (NASDAQ: CRIS)
$6.86
-0.1200 ( -1.72% ) 29.7K
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Market Data
Open
$6.86
Previous close
$6.98
Volume
29.7K
Market cap
$40.49M
Day range
$6.77 - $7.12
52 week range
$3.80 - $17.49
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 60 | May 07, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| ars | Annual reports | 1 | Apr 10, 2024 |
| def | Proxies and info statements | 6 | Apr 10, 2024 |
| pre | Proxies and info statements | 6 | Mar 29, 2024 |
| 10-k | Annual reports | 86 | Feb 08, 2024 |
| 8-k | 8K-related | 16 | Feb 08, 2024 |
| 8-k | 8K-related | 30 | Jan 11, 2024 |
| 10-k/a | Quarterly Reports | 15 | Dec 21, 2023 |
| 10-q | Quarterly Reports | 58 | Nov 02, 2023 |